Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2025-12-25 @ 12:14 AM
NCT ID:
NCT05594758
Eligibility Criteria:
Inclusion Criteria:
• Patients who are suitable to receive Olverembatinib and for whom there is reasonable expectation that Olverembatinib may provide clinical benefit based on the medical judgment of their prescribing physician.
Exclusion Criteria:
* Existing risks of serious Arterial occlusive events (AOE), including myocardial infarction, stroke, stenosis of large arterial vessels of the brain, severe peripheral vascular disease, and recent revascularization procedures
* Existing risks of serious Venous thromboembolic events (VTEs), including deep venous thrombosis, pulmonary embolism, and retinal vein thrombosis
* Existing serious heart conditions, including acute/chronic heart failure, coronary artery disease
* Existing conditions of severe liver malfunction
* Existing conditions of severe myelosuppression
* Existing conditions of severe hemorrhage
* Pregnant or baby feeding
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT05594758
Study Brief:
Protocol Section:
NCT05594758